Back
Monopar Therapeutics Stock Price Chart
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
65
MNPR
Monopar Therapeutics
Last Price:
15.69
Seasonality Move:
4.72%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- The current trend is moderately bullish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.99 | Sell |
| 20-day SMA: | 10.91 | Buy |
| 50-day SMA: | 6.67 | Buy |
| 200-day SMA: | 4.16 | Buy |
| 8-day EMA: | 15.23 | Buy |
| 20-day EMA: | 12.19 | Buy |
| 50-day EMA: | 8.35 | Buy |
| 200-day EMA: | 5 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.11 | Buy |
| Relative Strength Index (14 RSI): | 57.85 | Buy |
| Chaikin Money Flow: | -72945 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.78 - 16.6) | Buy |
| Bollinger Bands (100): | (0.53 - 9.47) | Buy |
Monopar Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
- Monopar Therapeutics share price is 15.75 while MNPR 8-day simple moving average is 15.99, which is a Sell signal.
- The stock price of MNPR is 15.75 while Monopar Therapeutics 20-day SMA is 10.91, which makes it a Buy.
- Monopar Therapeutics 50-day simple moving average is 6.67 while MNPR share price is 15.75, making it a Buy technically.
- MNPR stock price is 15.75 and Monopar Therapeutics 200-day simple moving average is 4.16, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
65
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a Buy
The current Monopar Therapeutics [MNPR] share price is $15.75. The Score for MNPR is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
55.45M
Price in USD:
15.75
Share Volume:
126.05K
Monopar Therapeutics 52-Week Range
52-Week High:
38.50
52-Week Low:
1.37
Buy
65
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?
The Monopar Therapeutics stock price is 15.75 USD today. -
Will MNPR stock go up or go down?
Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Monopar Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
- Monopar Therapeutics share price is 15.75 while MNPR 8-day exponential moving average is 15.23, which is a Buy signal.
- The stock price of MNPR is 15.75 while Monopar Therapeutics 20-day EMA is 12.19, which makes it a Buy.
- Monopar Therapeutics 50-day exponential moving average is 8.35 while MNPR share price is 15.75, making it a Buy technically.
- MNPR stock price is 15.75 and Monopar Therapeutics 200-day simple moving average is 5.00, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.34 per share, and a decrease next year of $0.21 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
- MNPR Moving Average Covergence Divergence (MACD) indicator is 3.11, suggesting Monopar Therapeutics is a Buy
- Monopar Therapeutics Relative Strength Index (RSI) is 57.85, which suggest Monopar Therapeutics is overbought
- The Bollinger Bands (25) for Monopar Therapeutics is (2.78 - 16.6), which suggest Monopar Therapeutics is a Buy
- The Bollinger Bands (100) for Monopar Therapeutics is (0.53 - 9.47), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.